Hoda Abbasizanjani

Featured in: Favicon

Articles

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England - Nature Communications

Jul 31, 2024 | nature.com | Samantha Ip |Fatemeh Torabi |Hoda Abbasizanjani |Ashley Akbari |Rachel Denholm |AMITAVA BANERJEE | +4 more

AbstractThe first dose of COVID-19 vaccines led to an overall reduction in cardiovascular events, and in rare cases, cardiovascular complications. There is less information about the effect of second and booster doses on cardiovascular diseases.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.